Subscribe To
PODD / Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
![Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think](https://cdn.snapi.dev/images/v1/v/q/default17-2120743.jpg)
PODD News
![Insulet (PODD) stock up 14% on positive earnings and growth forecast Insulet (PODD) stock up 14% on positive earnings and growth forecast](https://cdn.snapi.dev/images/v1/g/b/insulet-2139494.jpg)
By Invezz
November 3, 2023
Insulet (PODD) stock up 14% on positive earnings and growth forecast
Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company' more_horizontal
![Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name. Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.](https://cdn.snapi.dev/images/v1/q/0/medical21-2139251.jpg)
By Barrons
November 3, 2023
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.
The automated insulin technology developer posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier. more_horizontal
![Insulet shares rebound after results top estimates Insulet shares rebound after results top estimates](https://cdn.snapi.dev/images/v1/u/g/medical20-2138859.jpg)
By Market Watch
November 3, 2023
Insulet shares rebound after results top estimates
Insulet Corp. shares PODD, +1.98% climbed 10% premarket on Friday after the insulin pump maker late Thursday reported third-quarter results that beat more_horizontal
![Insulet Corporation (PODD) Q3 2023 Earnings Call Transcript Insulet Corporation (PODD) Q3 2023 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/h/m/transcript8-2138322.jpg)
By Seeking Alpha
November 2, 2023
Insulet Corporation (PODD) Q3 2023 Earnings Call Transcript
Insulet Corporation (NASDAQ:PODD ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Deborah Gordon - Vice President, more_horizontal
![Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates](https://cdn.snapi.dev/images/v1/e/c/default30-2138075.jpg)
By Zacks Investment Research
November 2, 2023
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2023, it could be more_horizontal
![Insulet Corporation: Still No Bargain Insulet Corporation: Still No Bargain](https://cdn.snapi.dev/images/v1/n/q/image-1488552777-2129145.jpg)
By Seeking Alpha
October 30, 2023
Insulet Corporation: Still No Bargain
Today, we take a look at Insulet Corporation, a mid-cap medical device concern. The company is focused on developing and marketing insulin delivery sy more_horizontal
![Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think](https://cdn.snapi.dev/images/v1/v/q/default17-2120743.jpg)
By Zacks Investment Research
October 25, 2023
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal
![Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround](https://cdn.snapi.dev/images/v1/b/9/default1-2107081.jpg)
By Zacks Investment Research
October 17, 2023
Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measu more_horizontal